Osteosarcopenia and Hard Clinical Endpoints: Biological Rationale, Diagnostic Uncertainty and Inconsistent Prognostic Evidence
European Journal of Clinical Investigation · 2026-11 · 56 (11)
DOI: 10.1111/eci.70283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 11.11.2026. Verfasst von Joshua Bemporad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy. Hauptthemen laut MEDLINE: Sarcopenia, Osteoporosis. Die Arbeit nennt 125 Literaturangaben.
Abstract (Originalsprache)
Background
Osteosarcopenia, the coexistence of osteoporosis and sarcopenia, has emerged as a candidate musculoskeletal aging syndrome, supported by a growing body of mechanistic evidence on crosstalk between bone, muscle and adipose tissue, including mechanotransduction, myokine and osteokine signalling, inflammaging, mitochondrial dysfunction, marrow adiposity, myosteatosis and impaired regenerative capacity. Whether this biological convergence translates into a prognostically autonomous clinical entity remains uncertain. Operational definitions still combine criteria developed separately for osteoporosis and sarcopenia, biologically integrated diagnostic frameworks and validated biomarkers are lacking and longitudinal cohorts differ substantially in case definitions, populations and adjustment strategies. In this narrative review we critically appraise the biological, diagnostic and epidemiological evidence on osteosarcopenia, focusing on hard clinical endpoints (mortality, fractures, falls).
Methods
Narrative review based on a structured search of PubMed/MEDLINE, Scopus and Web of Science (inception to October 2026), prioritizing prospective cohorts reporting mortality, fractures, or falls, meta‐analyses and consensus documents.
Results
Prospective studies suggest that osteosarcopenia identifies older adults at increased risk of adverse outcomes; however, recent meta‐analytic evidence, including formal interaction analyses, does not consistently support additive or multiplicative effects beyond isolated osteoporosis or sarcopenia alone. Fracture risk appears largely driven by skeletal fragility, while mortality associations overlap substantially with frailty burden and aging‐related vulnerability.
Conclusions
Osteosarcopenia is best understood, at present, as a marker of integrated musculoskeletal vulnerability along an aging continuum rather than a discrete syndrome. Future research should prioritize harmonized definitions, biologically integrated phenotyping and adequately powered cohorts capable of testing interaction effects between skeletal and muscular impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy.
- Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Campus Bio-Medico, Rome, Italy.
- UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy.
- UOSD Endocrinologia e Diabetologia, Azienda Ospedaliera San Giovanni-Addolorata-Britannico, Rome, Italy.
ORCID-Profile: Joshua Bemporad, Andrea Palermo
Zitieren
APA
Bemporad, J., Palermo, A., Paradiso, A., Santonati, A., & Cesareo, R. (2026). Osteosarcopenia and Hard Clinical Endpoints: Biological Rationale, Diagnostic Uncertainty and Inconsistent Prognostic Evidence. European Journal of Clinical Investigation, 56(11). https://doi.org/10.1111/eci.70283
Vancouver
Bemporad J, Palermo A, Paradiso A, Santonati A, Cesareo R. Osteosarcopenia and Hard Clinical Endpoints: Biological Rationale, Diagnostic Uncertainty and Inconsistent Prognostic Evidence. European Journal of Clinical Investigation. 2026;56(11). doi:10.1111/eci.70283
BibTeX
@article{Bemporad2026,
author = {Bemporad, Joshua and Palermo, Andrea and Paradiso, Antonella and Santonati, Assunta and Cesareo, Roberto},
title = {Osteosarcopenia and Hard Clinical Endpoints: Biological Rationale, Diagnostic Uncertainty and Inconsistent Prognostic Evidence},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {11},
doi = {10.1111/eci.70283}
}
EUVIMED